Office of Children and Family Services

News Article
Tuesday, December 11, 2018

Product Recall: Infants’ Pain Reliever/Fever Reducer

The U.S. Food & Drug Administration (FDA) says Tris Pharma, Inc. voluntarily recalled three lots of Infants’ Ibuprofen Concentrated Oral Suspension, USP (NSAID) 50 mg per 1.25 mL, saying these lots have been found to potentially have higher concentrations of ibuprofen.

This pain reliever/fever reducer was packaged in 0.5 oz. bottles for the recalled lots listed on the FDA website.

Translate This Page

Google Translation Disclaimer